T1	CHEM 82 99	ANTIRRETROVIRALES
#1	AnnotatorNotes T1	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T2	PROC 106 141	PROFILAXIS POST-EXPOSICIÓN AL VIH-1
#2	AnnotatorNotes T2	C0948838; HIV post exposure prophylaxis; Therapeutic or Preventive Procedure
T3	CHEM 143 152	TENOFOVIR
#3	AnnotatorNotes T3	C0384228; tenofovir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T4	CHEM 155 168	EMTRICITABINA
#4	AnnotatorNotes T4	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T5	CHEM 170 177	TRUVADA
#5	AnnotatorNotes T5	C1528494; Truvada; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T6	CHEM 204 211	KALETRA
#6	AnnotatorNotes T6	C0939357; Kaletra; Organic Chemical · Pharmacologic Substance
T7	CHEM 218 227	TENOFOVIR
#7	AnnotatorNotes T7	C0384228; tenofovir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T8	CHEM 230 243	EMTRICITABINA
#8	AnnotatorNotes T8	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T9	CHEM 246 256	COBICISTAT
#9	AnnotatorNotes T9	C3177235; cobicistat; Organic Chemical · Pharmacologic Substance
T10	CHEM 259 271	ELVITEGRAVIR
#10	AnnotatorNotes T10	C2606637; elvitegravir; Organic Chemical · Pharmacologic Substance
T11	PROC 289 332	ESTUDIO PROSPECTIVO, ALEATORIZADO Y ABIERTO
#11	AnnotatorNotes T11	C0033522; Prospective Studies; Research Activity + C1709323; Open Label Study; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T12	PROC 360 384	prevención infección HIV
#12	AnnotatorNotes T12	C1096319; Prophylaxis against HIV infection; Therapeutic or Preventive Procedure
T13	DISO 371 384	infección HIV
#13	AnnotatorNotes T13	C0019693; HIV Infections; Disease or Syndrome
T14	LIVB 546 549	VIH
#14	AnnotatorNotes T14	C0019682; HIV; Virus
T15	CHEM 654 680	fármacos antirretrovirales
#15	AnnotatorNotes T15	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T16	PROC 1137 1161	Tratamiento con fármacos
#16	AnnotatorNotes T16	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T17	PROC 813 826	exploraciones
#17	AnnotatorNotes T17	C1280903; Exploration procedure; Therapeutic or Preventive Procedure
T18	CHEM 1098 1106	fármacos
#18	AnnotatorNotes T18	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T19	PROC 1114 1120	pautas
#19	AnnotatorNotes T19	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T20	PROC 728 754	consentimiento por escrito
#20	AnnotatorNotes T20	C0811746; Obtain written consent; Health Care Activity
T21	PROC 803 810	pruebas
#21	AnnotatorNotes T21	C1510438; Assay; Laboratory Procedure
T22	Observation 1069 1081	resistencias
#22	AnnotatorNotes T22	C3542449; Drug Resistance Status; Finding
T23	CHEM 1153 1161	fármacos
#23	AnnotatorNotes T23	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T24	CHEM 183 192	LOPINAVIR
#24	AnnotatorNotes T24	C0674432; lopinavir; Organic Chemical · Pharmacologic Substance
T25	CHEM 193 202	RITONAVIR
#25	AnnotatorNotes T25	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T26	CHEM 273 281	STRIBILD
#26	AnnotatorNotes T26	C3486540; Stribild; Organic Chemical · Pharmacologic Substance
T27	PROC 411 452	proxilaxis HIV post exposición accidental
T28	PROC 641 644	PEP
#27	AnnotatorNotes T28	C0948838; HIV post exposure prophylaxis; Therapeutic or Preventive Procedure
T29	Date 13 17	2014
T30	Date 117 132	POST-EXPOSICIÓN
T31	LIVB 381 384	HIV
#28	AnnotatorNotes T31	C0019682; HIV; Virus
T32	LIVB 422 425	HIV
#29	AnnotatorNotes T32	C0019682; HIV; Virus
T33	Date 426 441	post exposición
T34	Age 487 513	igual o superior a 18 años
T37	Date 619 627	actuales
T38	LIVB 875 919	Mujeres embarazadas, en periodo de lactancia
#30	AnnotatorNotes T38	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T39	LIVB 1000 1007	Sujetos
#31	AnnotatorNotes T39	C0681850; Study Subject; Group
T41	PHYS 953 964	embarazadas
#32	AnnotatorNotes T41	C0032961; Pregnancy; Organism Function
T40	Spec_cue 1032 1040	sospeche
T42	PHYS 883 894	embarazadas
#33	AnnotatorNotes T42	C0032961; Pregnancy; Organism Function
T43	PHYS 910 919	lactancia
#34	AnnotatorNotes T43	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T35	DISO 122 132	EXPOSICIÓN
#35	AnnotatorNotes T35	C0260339; Encounter due to contact with or exposure to communicable diseases; Finding [ICD-10: Z20]
T36	DISO 431 441	exposición
#36	AnnotatorNotes T36	C0260339; Encounter due to contact with or exposure to communicable diseases; Finding [ICD-10: Z20]
T44	DISO 532 549	exposición al VIH
#37	AnnotatorNotes T44	C0476549; Contact with and exposure to human immunodeficiency virus [HIV]; Finding [ICD-10: Z20.6]
T45	LIVB 136 141	VIH-1
#38	AnnotatorNotes T45	C0019704; HIV-1; Virus
T46	CHEM 1201 1235	productos en fase de investigación
#39	AnnotatorNotes T46	C0013230; Investigational New Drugs; Pharmacologic Substance
A1	Assertion T22 Speculated
A2	Assertion T16 Contraindicated
A3	Assertion T23 Contraindicated
A4	Status T44 History_of
#40	AnnotatorNotes T27	C0948838; HIV post exposure prophylaxis; Therapeutic or Preventive Procedure
#41	AnnotatorNotes T37	C0521116; Current (present time); Temporal Concept 
T47	Neg_cue 551 553	no
T48	Quantifier_or_Qualifier 554 565	ocupacional
A5	Assertion T48 Negated
#42	AnnotatorNotes T48	C0521127; Occupational; Functional Concept
R1	Used_for Arg1:T1 Arg2:T2	
R2	Overlap Arg1:T2 Arg2:T30	
R3	Combined_with Arg1:T3 Arg2:T4	
R5	Combined_with Arg1:T24 Arg2:T25	
R6	Combined_with Arg1:T5 Arg2:T24	
R7	Combined_with Arg1:T5 Arg2:T6	
R4	Combined_with Arg1:T3 Arg2:T24	
R8	Combined_with Arg1:T7 Arg2:T8	
R9	Combined_with Arg1:T8 Arg2:T9	
R10	Combined_with Arg1:T9 Arg2:T10	
R11	Used_for Arg1:T3 Arg2:T2	
R12	Used_for Arg1:T7 Arg2:T2	
R13	Before Arg1:T12 Arg2:T13	
R14	Causes Arg1:T31 Arg2:T13	
R15	Overlap Arg1:T27 Arg2:T33	
R16	Negation Arg1:T47 Arg2:T48	
R17	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T48	
T49	Observation 574 618	cumpla los requisitos de las recomendaciones
R18	Overlap Arg1:T49 Arg2:T37	
R19	Used_for Arg1:T15 Arg2:T28	
T50	Observation 760 784	participar en el estudio
#43	AnnotatorNotes T50	C1278516; Patient participation status; Finding
R20	Before Arg1:T20 Arg2:T50	
R21	Before Arg1:T20 Arg2:T21	
R22	Before Arg1:T20 Arg2:T17	
R25	Experiences Arg1:T38 Arg2:T42	
R26	Experiences Arg1:T38 Arg2:T43	
R27	Experiences Arg1:T38 Arg2:T41	
T51	PROC 988 995	estudio
#44	AnnotatorNotes T51	C0008976; Clinical Trials; Research Activity
R28	Overlap Arg1:T41 Arg2:T51	
R29	Experiences Arg1:T39 Arg2:T22	
R30	Overlap Arg1:T22 Arg2:T18	
R31	Used_for Arg1:T18 Arg2:T19	
R32	Speculation Arg1:T40 Arg2:T22	
R33	Experiences Arg1:T39 Arg2:T18	
R34	Used_for Arg1:T23 Arg2:T16	
R35	Used_for Arg1:T6 Arg2:T2	
R36	Used_for Arg1:T26 Arg2:T2	
R37	Before Arg1:T44 Arg2:T28	
R38	Before Arg1:T36 Arg2:T27	
R39	Before Arg1:T35 Arg2:T2	
R23	Overlap Arg1:T42 Arg2:T51	
R24	Overlap Arg1:T43 Arg2:T51	
T52	Observation 936 964	pretendan quedar embarazadas
#45	AnnotatorNotes T52	C0032992; Pregnancy, Planned; Finding
R40	Overlap Arg1:T52 Arg2:T51	
R41	Before Arg1:T52 Arg2:T41	
A6	Experiencer T38 Patient
A7	Status T41 Future
A8	Experiencer T39 Patient
